Table 6.

Overview of benefits of all BLVR techniques in the literature

Technique	Δ FEV mL	Δ FEV % pred.	Δ RV mL	Δ RV % pred.	Δ 6MWT m
Valve	77.5 (34.5–140)	13.7 (4.3–20.7)	440 (200–680)	-	40.8 (9.3–91.0)
Coil	130 (90.0–200)	12.1 (7.0–14.0)	420 (310–510)	16.5 (14.5–22.0%)	47.0 (14.6–84.0)
TVA	101 (64.0–141)	-	284 (108–406)	-	18.3 (6.2–30.5)
Overview of all mean complication rates
Technique	Pneumonia	COPD Exacerbation	PNX	Migration and replacement	Death
Valve	6.4 (0–11.7)	25.0 (4.6–64.0)	14.7 (4.2–29.2)	10.1 (1.5–20.0)	2.6 (0–8.6)
Coil	14.8 (0–46.0)	41.0 (10.8–87.0)	5.7 (0–11.6)	-	3.3 (0–8.0)
TVA	21.0 (18–23.0)	16.5 (9.0–24.0)	2.5 (2–3.0)	-	2.5 (2–3.0)

Data of benefits are shown mean (min–max)/Data of complications are shown mean % (min–max)

COPD: chronic obstructive pulmonary disease; FEV: forced expiration volume; Δ: change; M: month; PNX: pneumothorax; 6MWT: 6-minute walking test